FGF21 can protect against NAFLD/NASH by reducing hepatocyte stress and hepatic steatosis as well as directly protecting against inflammation and fibrosis, which is aimed at the pathological characteristics of NAFLD/NASH. Here, FGF21 is linked to metabolic dysfunction-associated steatohepatitis.